Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-066050

President & CEO sold 83,333 shares at $55.69 ($4,640,815)

  • President & CEO acquired 83,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
ROBIN HOWARD W President & CEO 2017-12-13 Option exercise +83,333 $11.34 $944,996 272,768 D
ROBIN HOWARD W President & CEO 2017-12-13 Sale −83,333 $55.69 $4,640,815 189,435 D
Derivatives
ROBIN HOWARD W President & CEO 2017-12-13 Option exercise · Stock Option −83,333 83,333 D
Open-market sales · 83,333 sh · avg $55.69 · $4,640,815
Loading xslF345X03/doc4.xml…